Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide
Lu Lu(Chinese Academy of Medical Sciences & Peking Union Medical College), Qiang Shen(Peking University), Hye-Jin Kim(The University of Texas MD Anderson Cancer Center), Jiali Dong(Chinese Academy of Medical Sciences & Peking Union Medical College), Saijun Fan(Chinese Academy of Medical Sciences & Peking Union Medical College), Qing Xia(Boston University), Tao Yin(Rutgers, The State University of New Jersey), Dan Zhang(Shandong University of Traditional Chinese Medicine), Lili Wang(Soochow University)
Cited by 170
Related Papers
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
|Clinical Cancer Research|2020|576
BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells
|Science|1999|494
In vivo renal clearance, biodistribution, toxicity of gold nanoclusters
|Biomaterials|2012|486
Ultrasmall Au<sub>10−12</sub>(SG)<sub>10−12</sub> Nanomolecules for High Tumor Specificity and Cancer Radiotherapy
|Advanced Materials|2014|438
Enhanced Tumor Accumulation of Sub‐2 nm Gold Nanoclusters for Cancer Radiation Therapy
|Advanced Healthcare Materials|2013|372